150 related articles for article (PubMed ID: 2522764)
1. Anastomotic tensile strength following in situ replacement of an infected abdominal aortic graft.
Vetsch R; Bandyk DF; Schmitt DD; Bergamini TM; Storey JD; Towne JB
Arch Surg; 1989 Apr; 124(4):425-8. PubMed ID: 2522764
[TBL] [Abstract][Full Text] [Related]
2. Infection of vascular prostheses caused by bacterial biofilms.
Bergamini TM; Bandyk DF; Govostis D; Kaebnick HW; Towne JB
J Vasc Surg; 1988 Jan; 7(1):21-30. PubMed ID: 2961893
[TBL] [Abstract][Full Text] [Related]
3. Primary anastomotic bonding in polytetrafluoroethylene grafts?
Quiñones-Baldrich WJ; Ziomek S; Henderson T; Moore WS
J Vasc Surg; 1987 Feb; 5(2):311-8. PubMed ID: 2950244
[TBL] [Abstract][Full Text] [Related]
4. Treatment of vascular graft infection by in situ replacement with a rifampin-bonded gelatin-sealed Dacron graft.
Goëau-Brissonnière O; Mercier F; Nicolas MH; Bacourt F; Coggia M; Lebrault C; Pechère JC
J Vasc Surg; 1994 Apr; 19(4):739-41. PubMed ID: 8164289
[TBL] [Abstract][Full Text] [Related]
5. Treatment of bacteria-biofilm graft infection by in situ replacement in normal and immune-deficient states.
Bandyk DF; Kinney EV; Riefsnyder TI; Kelly H; Towne JB
J Vasc Surg; 1993 Sep; 18(3):398-405; discussion 405-6. PubMed ID: 8104253
[TBL] [Abstract][Full Text] [Related]
6. Identification of Staphylococcus epidermidis vascular graft infections: a comparison of culture techniques.
Bergamini TM; Bandyk DF; Govostis D; Vetsch R; Towne JB
J Vasc Surg; 1989 May; 9(5):665-70. PubMed ID: 2524605
[TBL] [Abstract][Full Text] [Related]
7. [An experimental study of the strength in arterial prosthetic anastomoses: relationship between anastomotic tensile strength and its organization].
Ashizawa K
Nihon Geka Gakkai Zasshi; 1991 Jul; 92(7):874-84. PubMed ID: 1832205
[TBL] [Abstract][Full Text] [Related]
8. Does in situ replacement of a staphylococcal infected vascular graft with a rifampicin impregnated gelatin sealed Dacron graft reduce the incidence of subsequent infection?
Vicaretti M; Hawthorne W; Ao PY; Fletcher JP
Int Angiol; 1999 Sep; 18(3):225-32. PubMed ID: 10688422
[TBL] [Abstract][Full Text] [Related]
9. Treatment of vascular graft infection by in situ replacement with cryopreserved aortic allografts: an experimental study.
Knosalla C; Goëau-Brissonnière O; Leflon V; Bruneval P; Eugène M; Pechère JC; Koskas F; Nicolas MH; Leschi JP; Gerota J; Kieffer E
J Vasc Surg; 1998 Apr; 27(4):689-98. PubMed ID: 9576083
[TBL] [Abstract][Full Text] [Related]
10. Use of an antibiotic-bonded graft for in situ reconstruction after prosthetic graft infections.
Colburn MD; Moore WS; Chvapil M; Gelabert HA; Quiñones-Baldrich WJ
J Vasc Surg; 1992 Oct; 16(4):651-8; discussion 658-60. PubMed ID: 1344030
[TBL] [Abstract][Full Text] [Related]
11. Antistaphylococcal activity of rifampin-bonded gelatin-impregnated Dacron grafts.
Gahtan V; Esses GE; Bandyk DF; Nelson RT; Dupont E; Mills JL
J Surg Res; 1995 Jan; 58(1):105-10. PubMed ID: 7830398
[TBL] [Abstract][Full Text] [Related]
12. Anastomotic femoral pseudoaneurysm: an investigation of occult infection as an etiologic factor.
Seabrook GR; Schmitt DD; Bandyk DF; Edmiston CE; Krepel CJ; Towne JB
J Vasc Surg; 1990 May; 11(5):629-34. PubMed ID: 2139897
[TBL] [Abstract][Full Text] [Related]
13. Does in situ replacement of a staphylococcal infected vascular graft with a rifampicin impregnated gelatin sealed Dacron graft reduce the incidence of subsequent infection?
Vicaretti M; Hawthorne W; Ao PY; Fletcher JP
Int Angiol; 2000 Jun; 19(2):158-65. PubMed ID: 10905800
[TBL] [Abstract][Full Text] [Related]
14. In situ replacement of arterial prosthesis infected by bacterial biofilms: long-term follow-up.
Towne JB; Seabrook GR; Bandyk D; Freischlag JA; Edmiston CE
J Vasc Surg; 1994 Feb; 19(2):226-33; discussion 233-5. PubMed ID: 8114184
[TBL] [Abstract][Full Text] [Related]
15. In vitro laser recanalization of chronically occluded prosthetic grafts.
Kaelin LD; Klingman N; Normann SJ; Seeger JM
Lasers Surg Med; 1992; 12(4):410-6. PubMed ID: 1386644
[TBL] [Abstract][Full Text] [Related]
16. [Dacron and polytetrafluoroethylene aorto-bifemoral grafts].
Davidović LB; Lotina SI; Kostić DM; Cinara II; Cvetković SD; Stojanović PL; Velimirović LB; Marković DM; Pejkić SL; Pavlović G
Srp Arh Celok Lek; 1997; 125(3-4):75-83. PubMed ID: 9221522
[TBL] [Abstract][Full Text] [Related]
17. Partial replacement of an infected arterial graft by a new prosthetic polytetrafluoroethylene segment: a new therapeutic option.
Miller JH
J Vasc Surg; 1993 Mar; 17(3):546-58. PubMed ID: 8445751
[TBL] [Abstract][Full Text] [Related]
18. Bacterial and clinical criteria relating to the outcome of patients undergoing in situ replacement of infected abdominal aortic grafts.
Speziale F; Rizzo L; Sbarigia E; Giannoni MF; Massucci M; Maraglino C; Santoro E; Fiorani P
Eur J Vasc Endovasc Surg; 1997 Feb; 13(2):127-33. PubMed ID: 9091143
[TBL] [Abstract][Full Text] [Related]
19. The natural history of bacterial biofilm graft infection.
Bergamini TM; Corpus RA; Brittian KR; Peyton JC; Cheadle WG
J Surg Res; 1994 May; 56(5):393-6. PubMed ID: 8170137
[TBL] [Abstract][Full Text] [Related]
20. Prevention of graft infection by use of prostheses bonded with a rifampin/collagen release system.
Chervu A; Moore WS; Gelabert HA; Colburn MD; Chvapil M
J Vasc Surg; 1991 Oct; 14(4):521-4; discussion 524-5. PubMed ID: 1833564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
